Samsung's New Patent Reads Body Fat From Two Points on Your Skin at Once
Most fitness wearables give you a single number for body composition. Samsung's new patent describes a device that takes two different electrical readings at the same time, giving a much fuller picture of what's going on under your skin.
What Samsung's two-electrode body scan actually does
Imagine pressing a smart watch against your wrist and, in that same moment, touching another part of the device with your other hand. Your body completes a tiny electrical circuit, and the device uses the resistance of that signal passing through you to estimate things like body fat, muscle mass, or hydration levels.
That's roughly how bioelectrical impedance works, and Samsung already uses it in some Galaxy wearables. What this patent describes is doing two of those measurements at once: one focused tightly on the spot where the device touches your skin (local impedance), and one that maps a much larger stretch of your body as the signal travels between both contact points (area impedance).
Combining the two readings at the same moment, rather than in separate sessions, gives the device more data to work with. The result, according to the filing, is more detailed body information shown right on the display, without asking you to change how you're wearing or holding the device.
How the device reads local and area impedance together
The device has two sets of electrodes on different surfaces of its housing. The first electrodes, on one face of the device, press against a specific spot on the user's body, such as the wrist. The second electrodes, on another face, make contact when the user touches the device with another part of the body, like a finger.
With both contact points active simultaneously, the processor measures two things at once:
- Local impedance: the electrical resistance of the tissue right at the first contact point (the wrist, for example)
- Area impedance: the electrical resistance across a larger path through the body, from the first contact point to the second (wrist to fingertip, for instance)
Bioelectrical impedance analysis (BIA), the underlying technique, works by sending a very small, imperceptible electrical current through the body and measuring how much resistance different tissues offer. Fat, muscle, and water conduct electricity differently, so the resistance reading can be used to estimate body composition.
By capturing both a narrow, local reading and a broader, cross-body reading at the same moment, the processor can cross-reference the two signals to produce more detailed and accurate body composition data than a single measurement could provide. That output is then shown directly on the device's display.
What this means for wearable health tracking
Most consumer wearables that do body composition analysis take a single impedance reading along one fixed path through the body. Getting two simultaneous readings, one local and one wide-area, means the device has more information to work from without requiring you to stand on a scale or hold a separate device.
For Samsung Galaxy Watch users, this could mean more reliable body fat or muscle estimates from a device you're already wearing, without adding extra steps. The broader signal path also means the reading isn't just about your wrist, which is a known limitation of single-point wrist-based measurements today.
This is a meaningful incremental step for wearable health tech, not a dramatic leap. Samsung is clearly trying to close the accuracy gap between a $5,000 clinical body composition scanner and a watch you wear to the gym. Whether two simultaneous readings are enough to do that remains to be seen, but the engineering approach here is sensible and grounded in real limitations of current devices.
Which company should we read for you?
We track 17 companies here. Pro is the same weekly breakdown for any company you choose, delivered privately. Type a name and we'll scope it and send you a quote.
Get one Big Tech patent every Sunday
Plain English, intelligent commentary, no hype. Free.
Editorial commentary on a publicly published patent application. Not legal advice.